The diagnosis of breast cancer is based on the staging system, which, apart from purely anatomical information (tumor, node, metastasis), includes also prognostic information related to tumor biology such as tumor grade, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and gene expression data if available (36). This evidence concerns the gene ERBB2 and breast carcinoma.